` POLX (Polarean Imaging PLC) vs FTSE All Share Index Comparison - Alpha Spread

POLX
vs
F
FTSE All Share Index

Over the past 12 months, POLX has outperformed FTSE All Share Index, delivering a return of -95% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
POLX vs FTSE All Share Index

Loading
POLX
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
POLX vs FTSE All Share Index

Loading
POLX
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
POLX vs FTSE All Share Index

Loading
POLX
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Polarean Imaging PLC vs Peers

FTSE All Share Index
POLX
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Polarean Imaging PLC
Glance View

Market Cap
965.6k GBX
Industry
Health Care

Polarean Imaging Plc.operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company is headquartered in Durham, North Carolina and currently employs 21 full-time employees. The company went IPO on 2018-03-29. The firm with its subsidiaries operates in the medical imaging market and develops equipment to enable existing magnetic resonance imaging (MRI) systems. The firm develops equipment that enables existing MRI systems to attain an improved level of pulmonary function imaging and specializes in the use of hyperpolarised Xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue barrier, and into the pulmonary bloodstream. 129Xe used to evaluate pulmonary function and to visualize the lung using MRI. The firm operates in an area of unmet medical need and its technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform.

POLX Intrinsic Value
Not Available
Back to Top